載入...
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers
Approximately 50% of high-grade serous ovarian cancers (HGSOCs) have defects in genes involved in homologous recombination (HR) (i.e., BRCA1/2). Preclinical models to optimize therapeutic strategies for HR-deficient (HRD) HGSOC are lacking. We developed a preclinical platform for HRD HGSOCs that inc...
Na minha lista:
發表在: | JCI Insight |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
American Society for Clinical Investigation
2017
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214535/ https://ncbi.nlm.nih.gov/pubmed/28097235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89760 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|